Insulet Surges 77.2% in a Year: What's Behind the Rally?

Insulet Corporation (PODD) has seen its shares rise 77.2% in the past year, outperforming the industry and S&P 500 Composite. The company's strong momentum is driven by strategic market expansion efforts, including FDA clearance for type 2 label expansion for Omnipod 5, and a focus on delivering consumer-focused innovation. With healthy fundamentals and strong growth opportunities, Insulet appears to be a solid wealth creator for its investors.